Media release
From:
Attachments
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Journal/
conference: PLOS One
conference: PLOS One
Research:Paper
Organisation/s:
Massachusetts General Hospital and Harvard Medical School, USA; Harvard T.H. Chan School of Public Health, USA; Rush Medical College, USA; Brigham and Women’s Hospital, USA
Funder:
This work was supported by U.S. National Institutes of Health (NIH) grants [U01 CA176726; K23 DK125838; U01 AG062682; RF1 AG067744], Stuart and Suzanne Steele MGH Research Scholar Award to Dr Chan. The content is solely the responsibility of the authors. The funders had no role in study design, data collection, analysis, decision to publish, or manuscript preparation.
Competing interests: Dr Chan served as a consultant for Bayer Pharma AG, Pfizer Inc., and Boehringer Ingelheim. Dr. Kochar served on an advisory board to Pfizer. This study was not funded by Bayer Pharma AG, Boehringer Ingelheim, or Pfizer Inc. No other conflict of interest exists. The other authors declare that they have no conflicts of interest.